[1]
Revenko, O., Kovalyshyn, V., Yashchenko, A., Wallace, J. and Zayachkivska, O. 2021. HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG ATB-340 TREATMENT POTENTIALLY REDUCES MESENTERIC METAFLAMMATION IN THE EXPERIMENTAL AGE- AND HIGH FRUCTOSE DIETARY-INDUCED INJURY. Proceeding of the Shevchenko Scientific Society. Medical Sciences. 64, 1 (Jun. 2021). DOI:https://doi.org/10.25040/ntsh2021.01.09.